Vasopressor and Inotrope Selection

This CME/CE course on Vasopressor and Inotrope Selection is tailored for healthcare professionals involved in critical care, emergency medicine, anesthesiology, and cardiology. The course provides a comprehensive overview of the pharmacologic agents used to manage shock, focusing on vasopressors and inotropes. Shock, whether hypovolemic, cardiogenic, obstructive, or distributive, presents a complex clinical challenge that requires precise diagnosis and targeted therapeutic strategies. This course emphasizes the recognition of varying shock presentations, the pathophysiological rationale behind pharmacologic choices, and practical algorithms for intervention.

Participants will learn to select the most appropriate vasopressor or inotrope based on the type of shock and individual patient parameters. The course will cover agents such as norepinephrine, dopamine, epinephrine, phenylephrine, vasopressin, and dobutamine, along with evidence-based guidelines for their use. Additional content explores monitoring hemodynamic responses, avoiding overtreatment, and setting clear therapy goals. Through case-based discussions, attendees will refine their clinical judgment and optimize treatment protocols to improve patient outcomes. This program aims to bridge the gap between theoretical understanding and bedside application, equipping clinicians with the confidence and skills to manage critically ill patients effectively.

Educational Objectives

• Identify the varying clinical presentations of different types of shock, including hypovolemic, distributive, cardiogenic, and obstructive shock.
• Demonstrate appropriate selection and titration of vasopressors and inotropes based on patient-specific hemodynamic goals.
• Establish evidence-based therapeutic goals for shock management, including MAP targets and markers of end-organ perfusion.

Who Should Do This Course

This course is ideal for Physicians, Registered Nurses, Nurse Practitioners, and Physician Assistants working in Emergency Medicine, Critical Care Medicine, Cardiology, and Anesthesiology. It is also highly relevant for ICU and trauma specialists involved in the hemodynamic management of acutely ill patients.

Did You Know?

• Shock is responsible for over 1 million hospital admissions annually in the United States. (Source: National Center for Health Statistics, 2022)
• Norepinephrine is the first-line vasopressor recommended by the Surviving Sepsis Campaign for septic shock. (Source: SCCM Guidelines, 2021)
• Inotropes like dobutamine are commonly used in cardiogenic shock to improve cardiac output. (Source: AHA Heart Failure Guidelines, 2022)
• Mortality from untreated septic shock can exceed 40%. Early vasopressor use is associated with improved survival. (Source: NEJM, 2017)
• Vasopressin is often used as an adjunct to norepinephrine in refractory shock cases. (Source: Crit Care Med, 2019)